Narahari Narayan Palei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Narahari Narayan Palei has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Jayaraman Rajangam
Shri Venkateshwara College of Pharmacy, Ariyur, Puducherry, India
8 shared publications - Bibhash Chandra Mohanta
Department of Pharmacy, School of Health Science, Central University of South Bihar, Gaya, India
4 shared publications - Biswa Mohan Sahoo
School of Pharmacy and Life Sciences, Centurion University of Technology and Management, Bhubaneswar, Odisha, India
4 shared publications Seema Yadav
4 shared publicationsAbhishek Singh
3 shared publicationsAnuradha Mishra
Amity Institute of Pharmacy, Amity University Uttar Pradesh, Lucknow Campus, Lucknow, India
3 shared publications
Latest Publications
- 30 September 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27  (7) , 317
Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities
- 30 September 2026
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27  (7) , 317
Chitosan-Based Nose-to-Brain Drug Delivery for Management of Neurological Disorders: Intrinsic Neuroprotective Action and Carrier Capabilities
- 14 July 2026
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 25, 1-28
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials
Exosomes represent a promising class of naturally produced nanoparticles that exist at the nanoscale and carry a negative surface charge under physiological conditions. These tiny membranebound vesicles are released by cells throughout the body and function as biological messengers, transporting various molecular cargos between cells and facilitating critical cell-to-cell communication pathways. Existing therapies for neurodegenerative disorders face two critical barriers: they cannot precisely target the affected brain areas, and the blood-brain barrier blocks most potential treatments from entering the brain. Exosomes offer a promising solution to these challenges. Unlike most synthetic drug delivery systems that struggle to penetrate the brain's protective barrier, these naturally derived nanocarriers exhibit an inherent capacity to traverse the blood–brain barrier. This unique property, combined with their capacity for efficient intracellular delivery of therapeutic payloads, positions exosomes as an exciting platform for transporting pharmaceutical agents to the affected neural tissues. Through strategic engineering and modification, these vesicles can be transformed into highly precise delivery vehicles capable of targeting specific organs, tissues, or even individual cell types. This review explores the therapeutic potential and drug delivery applications of exosomes in the management of major neurodegenerative disorders. This review provides an in-depth examination of exosome biogenesis, current isolation methodologies, and surface engineering strategies, while critically evaluating the strengths and limitations of each approach. In addition, this review summarizes the current preclinical models and provides an overview of ongoing clinical trials investigating exosome-based therapies for neurological disorders.
- 14 July 2026
- Published by Bentham Science Publishers Ltd. in CNS & Neurological Disorders - Drug Targets
- Vol. 25, 1-28
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials
Exosomes represent a promising class of naturally produced nanoparticles that exist at the nanoscale and carry a negative surface charge under physiological conditions. These tiny membranebound vesicles are released by cells throughout the body and function as biological messengers, transporting various molecular cargos between cells and facilitating critical cell-to-cell communication pathways. Existing therapies for neurodegenerative disorders face two critical barriers: they cannot precisely target the affected brain areas, and the blood-brain barrier blocks most potential treatments from entering the brain. Exosomes offer a promising solution to these challenges. Unlike most synthetic drug delivery systems that struggle to penetrate the brain's protective barrier, these naturally derived nanocarriers exhibit an inherent capacity to traverse the blood–brain barrier. This unique property, combined with their capacity for efficient intracellular delivery of therapeutic payloads, positions exosomes as an exciting platform for transporting pharmaceutical agents to the affected neural tissues. Through strategic engineering and modification, these vesicles can be transformed into highly precise delivery vehicles capable of targeting specific organs, tissues, or even individual cell types. This review explores the therapeutic potential and drug delivery applications of exosomes in the management of major neurodegenerative disorders. This review provides an in-depth examination of exosome biogenesis, current isolation methodologies, and surface engineering strategies, while critically evaluating the strengths and limitations of each approach. In addition, this review summarizes the current preclinical models and provides an overview of ongoing clinical trials investigating exosome-based therapies for neurological disorders.
- 18 June 2026
- Published by Bentham Science Publishers Ltd. in Current Chemical Biology
- Vol. 20, 1-12
A Comprehensive Review on Ethnomedicinal Properties of Curcuma caesia Roxb.
Curcuma caesia Roxb. is commonly known as black turmeric. It is a valuable medicinal plant of the Zingiberaceae family in traditional systems of medicine. Its bioactive chemical constituents have been associated with a wide range of pharmacological properties, including antibacterial, antifungal, antioxidant, hepatoprotective, anticonvulsant, analgesic, anti-inflammatory, muscle relaxant, anti-diabetic, and antiurolithiatic activities, etc. The major chemical constituents present in Curcuma caesia are camphor, 1,8-cineole, ar-turmerone, ar-curcumene, and borneol, etc. In addition, the plant also contains anthocyanins, which impart its distinctive bluish-black color. But there are not enough comprehensive pharmacological investigations to support the efficacy and safety of several ethnomedical properties. There is also inadequate knowledge of the molecular mechanisms underlying its therapeutic benefits, with limited data on toxicity, safety profile, and long-term effects. There is a lack of randomized controlled trials (RCTs) with effect sizes and confidence intervals (CIs). So, this study focuses on current research findings on the phytochemistry and therapeutic uses of Curcuma caesia. This review also highlights the opportunities and challenges in new drug development using Curcuma caesia in natural product research.
- 18 June 2026
- Published by Bentham Science Publishers Ltd. in Current Chemical Biology
- Vol. 20, 1-12
A Comprehensive Review on Ethnomedicinal Properties of Curcuma caesia Roxb.
Curcuma caesia Roxb. is commonly known as black turmeric. It is a valuable medicinal plant of the Zingiberaceae family in traditional systems of medicine. Its bioactive chemical constituents have been associated with a wide range of pharmacological properties, including antibacterial, antifungal, antioxidant, hepatoprotective, anticonvulsant, analgesic, anti-inflammatory, muscle relaxant, anti-diabetic, and antiurolithiatic activities, etc. The major chemical constituents present in Curcuma caesia are camphor, 1,8-cineole, ar-turmerone, ar-curcumene, and borneol, etc. In addition, the plant also contains anthocyanins, which impart its distinctive bluish-black color. But there are not enough comprehensive pharmacological investigations to support the efficacy and safety of several ethnomedical properties. There is also inadequate knowledge of the molecular mechanisms underlying its therapeutic benefits, with limited data on toxicity, safety profile, and long-term effects. There is a lack of randomized controlled trials (RCTs) with effect sizes and confidence intervals (CIs). So, this study focuses on current research findings on the phytochemistry and therapeutic uses of Curcuma caesia. This review also highlights the opportunities and challenges in new drug development using Curcuma caesia in natural product research.
- 23 March 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16  (4) , 267
Formulation and Optimization of Ganciclovir-Loaded Chitosan-Tripolyphosphate Nanoparticles: In Silico Pharmacokinetic Prediction and Ex Vivo Intestinal Permeation Studies
- 23 March 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16  (4) , 267
Formulation and Optimization of Ganciclovir-Loaded Chitosan-Tripolyphosphate Nanoparticles: In Silico Pharmacokinetic Prediction and Ex Vivo Intestinal Permeation Studies
- Open Access
- 30 November 2025
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 18
The multifaceted therapeutic potential of Huangbai liniment: Modulation of IL, TGF-β and Nrf2 pathways in inflammation downregulation and diabetic wound healing
- 30 November 2025
- Published by Elsevier in Pharmacological Research - Modern Chinese Medicine
- Vol. 18
Open AccessThe multifaceted therapeutic potential of Huangbai liniment: Modulation of IL, TGF-β and Nrf2 pathways in inflammation downregulation and diabetic wound healing
- 27 September 2025
- Published by Springer Nature in BioNanoScience
- Vol. 15  (4) , 1-17
Lovastatin Loaded Piperine Enabled Nanostructured Lipid Carriers for Improvement of Ex vivo Permeation, Oral Bioavailability, and Antihyperlipidemic Activity
- 27 September 2025
- Published by Springer Nature in BioNanoScience
- Vol. 15  (4) , 1-17
Lovastatin Loaded Piperine Enabled Nanostructured Lipid Carriers for Improvement of Ex vivo Permeation, Oral Bioavailability, and Antihyperlipidemic Activity
- 1 September 2025
- Published by Bentham Science Publishers Ltd. in Current Microwave Chemistry
- Vol. 12  (2) , 105-115
Microwave-assisted Extraction: A Green and Sustainable Technology for the Extraction of Bioactive Compounds
Introduction: Microwave-assisted extraction (MAE) is a highly efficient technique used to extract bioactive compounds from plant materials. This method is gaining popularity due to its alignment with the principles of sustainable and green chemistry. Microwave radiation selectively heats polar molecules and their solvents, leading to a rapid increase in temperature within the sample. Methods: The MAE method can be performed solvent-free or utilize environmentally friendly solvents (e.g., water, ethanol), thereby reducing environmental pollution. Therefore, the selection of a suitable solvent is the most crucial parameter in an efficient extraction process. Reduced exposure to high temperatures minimizes the degradation of heat-sensitive compounds, resulting in higher-quality extracts. Results: This process significantly reduces extraction time compared to conventional methods, which typically require longer heating periods. MAE typically yields higher amounts of bioactive compounds in shorter times due to improved cell wall disruption and enhanced solvent penetration. Discussion: MAE improves atom economy by enhancing extraction efficiency, leading to less chemical waste. This technique minimizes the generation of hazardous substances during the extraction process. Conclusion: MAE is considered a green and sustainable technology due to its energy efficiency, reduced solvent usage, enhanced extraction yields, and lower environmental impact.
- 1 September 2025
- Published by Bentham Science Publishers Ltd. in Current Microwave Chemistry
- Vol. 12  (2) , 105-115
Microwave-assisted Extraction: A Green and Sustainable Technology for the Extraction of Bioactive Compounds
Introduction: Microwave-assisted extraction (MAE) is a highly efficient technique used to extract bioactive compounds from plant materials. This method is gaining popularity due to its alignment with the principles of sustainable and green chemistry. Microwave radiation selectively heats polar molecules and their solvents, leading to a rapid increase in temperature within the sample. Methods: The MAE method can be performed solvent-free or utilize environmentally friendly solvents (e.g., water, ethanol), thereby reducing environmental pollution. Therefore, the selection of a suitable solvent is the most crucial parameter in an efficient extraction process. Reduced exposure to high temperatures minimizes the degradation of heat-sensitive compounds, resulting in higher-quality extracts. Results: This process significantly reduces extraction time compared to conventional methods, which typically require longer heating periods. MAE typically yields higher amounts of bioactive compounds in shorter times due to improved cell wall disruption and enhanced solvent penetration. Discussion: MAE improves atom economy by enhancing extraction efficiency, leading to less chemical waste. This technique minimizes the generation of hazardous substances during the extraction process. Conclusion: MAE is considered a green and sustainable technology due to its energy efficiency, reduced solvent usage, enhanced extraction yields, and lower environmental impact.
- Open Access
Illustrating the Pathogenesis and Therapeutic Approaches of Epilepsy by Targeting Angiogenesis, Inflammation, and Oxidative Stress
Epilepsy is one of the most prevalent chronic medical conditions that really can affect individuals at any age. A broader study of the pathogenesis of the epileptic condition will probably serve as the cornerstone for the development of new antiepileptic remedies that aim to treat epilepsy symptomatically as well as prevent the epileptogenesis process or regulate its progression. Cellular changes in the brain include oxidative stress, neuroinflammation, inflammatory cell invasion, angiogenesis, and extracellular matrix associated changes. The extensive molecular profiling of epileptogenic tissue has revealed details on the molecular pathways that might start and sustain cellular changes. In healthy brains, epilepsy develops because of vascular disruptions, such as blood–brain barrier permeability and pathologic angiogenesis. Key inflammatory mediators are elevated during epileptic seizures, increasing the risk of recurrent seizures and resulting in secondary brain injury. Prostaglandins and cytokines are well-known inflammatory mediators in the brain and, after seizures, their production is increased. These inflammatory mediators may serve as therapeutic targets in the clinical research of novel antiepileptic medications. The functions of inflammatory mediators in epileptogenesis are covered in this review. Oxidative stress also plays a significant role in the pathogenesis of various neurological disorders, specifically epilepsy. Antioxidant therapy seems to be crucial for treating epileptic patients, as it prevents neuronal death by scavenging excess free radicals formed during the epileptic condition. The significance of antioxidants in mitochondrial dysfunction prevention and the relationship between oxidative stress and inflammation in epileptic patients are the major sections covered in this review.
Open AccessIllustrating the Pathogenesis and Therapeutic Approaches of Epilepsy by Targeting Angiogenesis, Inflammation, and Oxidative Stress
Epilepsy is one of the most prevalent chronic medical conditions that really can affect individuals at any age. A broader study of the pathogenesis of the epileptic condition will probably serve as the cornerstone for the development of new antiepileptic remedies that aim to treat epilepsy symptomatically as well as prevent the epileptogenesis process or regulate its progression. Cellular changes in the brain include oxidative stress, neuroinflammation, inflammatory cell invasion, angiogenesis, and extracellular matrix associated changes. The extensive molecular profiling of epileptogenic tissue has revealed details on the molecular pathways that might start and sustain cellular changes. In healthy brains, epilepsy develops because of vascular disruptions, such as blood–brain barrier permeability and pathologic angiogenesis. Key inflammatory mediators are elevated during epileptic seizures, increasing the risk of recurrent seizures and resulting in secondary brain injury. Prostaglandins and cytokines are well-known inflammatory mediators in the brain and, after seizures, their production is increased. These inflammatory mediators may serve as therapeutic targets in the clinical research of novel antiepileptic medications. The functions of inflammatory mediators in epileptogenesis are covered in this review. Oxidative stress also plays a significant role in the pathogenesis of various neurological disorders, specifically epilepsy. Antioxidant therapy seems to be crucial for treating epileptic patients, as it prevents neuronal death by scavenging excess free radicals formed during the epileptic condition. The significance of antioxidants in mitochondrial dysfunction prevention and the relationship between oxidative stress and inflammation in epileptic patients are the major sections covered in this review.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 31  (26) , 2105-2116
Formulation, Optimization, and Ex vivo Permeation Study of Ritonavir-loaded Solid Lipid Nanoparticles
Background: Ritonavir (RTV) is an antiviral drug that prevents human immunodeficiency virus (HIV). However, it has low bioavailability, which can be improved with the assistance of Solid Lipid Nanoparticles (SLNs). Objective: The present work aimed to formulate and optimize RTV-loaded SLNs using Box–Behnken design and evaluate the permeability coefficient using ex vivo permeation studies. Methods: RTV-SLNs were prepared using the ultrasonication technique. The SLN formulation was optimized based on particle size, % entrapment efficiency, and % cumulative drug release using response surface methodology resulting from Box-Behnken design. The Fourier-Transform Infrared spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), and transmission Electron Microscopy (TEM) studies were carried out for the characterization of optimized SLN formulation. Ex vivo permeation studies were also performed using chicken ileum. Results: The optimized RTV-SLNs had a particle size of 270.34 nm, polydispersity index of 0.157, and zeta potential of -25.2 mV. The % entrapment efficiency and % cumulative drug release were found to be 94.33% and 67.13%, respectively. The FT-IR study revealed that SLNs showed no significant interactions between the drug and lipid in the formulation. The % crystalline index of the RTV-loaded SLN formulation was found to be 44.31% compared to the reference value of 100% for lipids. TEM analysis showed spherical nanoparticles that were uniform in shape. The release kinetics data demonstrated the drug release behavior, followed by the Korsmeyer-Peppas model, and suggested that the release from SLNs followed the non-fiction diffusion. The permeability coefficient of optimized SLN formulation was found to be significantly (p < 0.05) more compared to free RTV suspension. The enhancement ratio results suggested that RTV-SLNs permeated significantly (p < 0.05) faster (approximately 3.5 times) as compared to free RTV suspension. Conclusion: The optimized RTV-SLNs could be a promising carrier for improving the oral bioavailability of RTV.
- 1 July 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 31  (26) , 2105-2116
Formulation, Optimization, and Ex vivo Permeation Study of Ritonavir-loaded Solid Lipid Nanoparticles
Background: Ritonavir (RTV) is an antiviral drug that prevents human immunodeficiency virus (HIV). However, it has low bioavailability, which can be improved with the assistance of Solid Lipid Nanoparticles (SLNs). Objective: The present work aimed to formulate and optimize RTV-loaded SLNs using Box–Behnken design and evaluate the permeability coefficient using ex vivo permeation studies. Methods: RTV-SLNs were prepared using the ultrasonication technique. The SLN formulation was optimized based on particle size, % entrapment efficiency, and % cumulative drug release using response surface methodology resulting from Box-Behnken design. The Fourier-Transform Infrared spectroscopy (FT-IR), Differential Scanning Calorimetry (DSC), and transmission Electron Microscopy (TEM) studies were carried out for the characterization of optimized SLN formulation. Ex vivo permeation studies were also performed using chicken ileum. Results: The optimized RTV-SLNs had a particle size of 270.34 nm, polydispersity index of 0.157, and zeta potential of -25.2 mV. The % entrapment efficiency and % cumulative drug release were found to be 94.33% and 67.13%, respectively. The FT-IR study revealed that SLNs showed no significant interactions between the drug and lipid in the formulation. The % crystalline index of the RTV-loaded SLN formulation was found to be 44.31% compared to the reference value of 100% for lipids. TEM analysis showed spherical nanoparticles that were uniform in shape. The release kinetics data demonstrated the drug release behavior, followed by the Korsmeyer-Peppas model, and suggested that the release from SLNs followed the non-fiction diffusion. The permeability coefficient of optimized SLN formulation was found to be significantly (p < 0.05) more compared to free RTV suspension. The enhancement ratio results suggested that RTV-SLNs permeated significantly (p < 0.05) faster (approximately 3.5 times) as compared to free RTV suspension. Conclusion: The optimized RTV-SLNs could be a promising carrier for improving the oral bioavailability of RTV.
- 11 June 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20  (3) , 1-21
Evaluation of Antimicrobial Efficacy and Cell Viability of Qbd Optimized Formulation of Curcumin-Loaded Nano-Emulgel
- 11 June 2025
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 20  (3) , 1-21
Evaluation of Antimicrobial Efficacy and Cell Viability of Qbd Optimized Formulation of Curcumin-Loaded Nano-Emulgel